Patents : |  |
| US Patent No. | Title |
| 7572814 | 3,5-dibenzoyl-4-phenyl-piperidine anti-cancer compounds
|
| 7579503 | BIS (thio-hydrazide amide) salts for treatment of cancers
|
| 7582614 | Use of myxoma virus for the therapeutic treatment of cancer and chronic viral infection
|
| 7582668 | Imidazoyl-benzamide anti-cancer agents
|
| 7582726 | VEGF receptor antagonists
|
| 7585997 | Compounds and compositions for treating dysproliferative diseases, and methods of use thereof
|
| 7588898 | Biomarker for gestational trophoblastic disease
|
| 7589068 | Inhibitors of Akt activity
|
| 7589098 | Methods and compositions utilizing quinazolinones
|
| 7589118 | IAP BIR domain binding compounds
|
| 7589119 | Methods for treating or preventing metastatic cancer using benzopyranone compounds
|
| 7579473 | c-Met modulators and methods of use
|
| 7579355 | Inhibitors of Akt activity
|
| 7579320 | IAP BIR domain binding compounds
|
| 7572821 | Compounds for the treatment of proliferative disorders
|
| 7572886 | Death associated proteins, and THAP1 and PAR4 pathways in apoptosis control
|
| 7575879 | Polypeptides homologous to VEGF and BMP1
|
| 7576074 | Receptor-type kinase modulators and methods of use
|
| 7576130 | Dihydroxyl compounds and compositions for cholesterol management and related uses
|
| 7576177 | Hsp peptides and analogs for modulation of immune responses via antigen presenting cells
|
| 7576191 | Tumor suppressor Killin
|
| 7576209 | Inhibitors of Akt activity
|
| 7579173 | Targeted glycosaminoglycan polymers by polymer grafting and methods of making and using the same
|
| 7579313 | Transglutaminase inhibitors and methods of use thereof
|
| 7589190 | Potent LNA oligonucleotides for the inhibition of HIF-1A expression
|
| 7592010 | Albumin fusion proteins
|
| 7608394 | Methods and compositions for phenotype identification based on nucleic acid methylation
|
| 7608635 | Pyrazole compounds that modulate HSP90 activity
|
| 7608643 | Compounds for inhibiting KSP kinesin activity
|
| 7608739 | Mitotic kinesin inhibitors
|
| 7611711 | VEGFR-3 inhibitor materials and methods
|
| 7611879 | 27877, 18080, 14081, 32140, 50352, 16658, 14223, 16002, 50566, 65552 and 65577 molecules and uses therefor
|
| 7612178 | Anti-IGF-1R antibodies and uses thereof
|
| 7615209 | Compositions of NDV and methods of use thereof for treatment of cancer
|
| 7618971 | Mitotic kinesin inhibitors
|
| 7618981 | Imidazopyridinyl-benzamide anti-cancer agents
|
| 7608260 | Stabilized immunoglobulins
|
| 7605266 | Azaindole inhibitors of Aurora kinases
|
| 7604799 | EphA4 Antibodies
|
| 7592422 | Modified plasminogen activator inhibitor type-1 and methods based thereon
|
| 7595038 | Methods of treatment using antibodies to follistatin-3
|
| 7595337 | Mitotic kinesin inhibitors
|
| 7597884 | Hyperglycosylated polypeptide variants and methods of use
|
| 7597886 | Tumor necrosis factor-gamma
|
| 7598239 | Conjugated psychotropic drugs and uses thereof
|
| 7598348 | Adiponectin receptor variant, AdipoR2v2
|
| 7598355 | Characterization of GRP94-ligand interactions and purification, screening, and therapeutic methods relating thereto
|
| 7599745 | Treating a tumor or the like with an electric field
|
| 7601359 | Compositions and methods for the prevention and treatment of primary and metastatic neoplastic diseases and infectious diseases with heat shock/stress proteins
|
| 7619006 | Conjugated psychotropic drugs and uses thereof
|
